| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.74B | +0.4% |
| Cost of Revenue | $2.41B | -0.6% |
| Gross Profit | $327.5M | +8.1% |
| R&D Expense | $80.6M | -2.6% |
| SG&A Expense | $214.4M | +3.3% |
| Operating Income | $86.6M | +24.0% |
| Pre-tax Income | -$23.5M | +76.8% |
| Income Tax | -$19.2M | +17.7% |
| Net Income | -$4.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $191.7M | +12.7% |
| Accounts Receivable | $334.3M | +7.6% |
| Inventory | $154.2M | +8.3% |
| Current Assets | $881.1M | +9.4% |
| Total Assets | $1.83B | +5.8% |
| Current Liabilities | $678.4M | +17.6% |
| Long-term Debt | $1.02B | -3.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.4M | -15.6% |
| Investing Cash Flow | -$45.6M | -1.1% |
| Financing Cash Flow | -$4.0M | +58.9% |
| +94.7% |
| EPS (Basic) | -$0.23 | +94.9% |
| EPS (Diluted) | -$0.23 | +94.9% |
| Total Liabilities |
| $1.92B |
| +3.1% |
| Stockholders' Equity | -$83.5M | +33.6% |